U.S. coronavirus task force response coordinator Dr. Deborah Birx will have a leading role in how the first drug to demonstrate a benefit in treating COVID-19 patients will be distributed to hospitals, the White House said on Friday.

A number of potential drugs for treating the coronavirus are in trials. There are some promising candidates but it’s unclear if they’ll help those who need them most

To fight the new coronavirus, researchers are investigating more than 60 drugs, including remdesivir and hydroxychloroquine and brand new ones. Here’s a breakdown of progress so far

A study suggests high blood pressure in people over 75 doesn't seem to raise the risk of death, leading researchers to question the use of medications for it in older people

Some dogs and cats may be passing gut microbes to their owners that withstand last-resort antibiotics, which can be needed to fight off pneumonia from a coronavirus infection

People with rheumatoid arthritis often take medicines that can have damaging side-effects, but a system that uses red light to deliver drugs exactly where they are needed could help

Sharon Osbourne hoped seeing their father''s battle with addiction would put her children off, but she was wrong.

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists.

Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the potential of accelerated new drug development.

Hackers linked to Iran have targeted staff at U.S. drugmaker Gilead Sciences Inc in recent weeks, according to publicly-available web archives reviewed by Reuters and three cybersecurity researchers, as the company races to deploy a treatment for the COVID-19 virus.

Pfizer Inc said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective.

Follow our live coronavirus updates HERE Coronavirus: the symptoms

An "evil" sex attacker who drugged and assaulted his victim after meeting him outside a London pub has been jailed.

Intensive care units battling a tripling of demand during the coronavirus crisis are experiencing critically low supplies of vital drugs, NHS doctors have claimed.

A swathe of US states were set to reopen businesses this week following mandatory lockdowns that have thrown nearly one in six American workers out of jobs.

A drug used to treat Ebola patients has shown "very promising" early results in a trial of people admitted to hospital with coronavirus.

A potential coronavirus vaccine being trialled by UK researchers will be rapidly produced in vast numbers if it proves effective.

Leading medical experts have described trials for a drug which could treat coronavirus as "a really promising first step" towards overcoming the disease.

Some 450 UK coronavirus patients will be recruited to take part in a new trial of a "promising" Covid-19 drug.

An experimental medicine that appears to help coronavirus patients recover faster has been given the green light for emergency use by US regulators.

The United States has authorised the emergency use of the Ebola drug remdesivir for treating coronavirus, clearing the way for the potential treatment of 140,000 patients around the country.

UK scientists have started testing an experimental Covid-19 drug which they hope will significantly improve the health of coronavirus patients.

The Trump administration failed to prepare for the onslaught of coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist has alleged in a whistleblower complaint.

Drug dealers are adopting new disguises so they can move around freeley during the coronavirus lockdown, a gang expert has said.

Hackers linked to Iran have targeted staff at U.S. drugmaker Gilead Sciences Inc in recent weeks, according to publicly-available web archives reviewed by Reuters and three cybersecurity researchers, as the company races to deploy a treatment for the COVID-19 virus. In one case, a fake email login page designed to steal passwords was sent in April to a top Gilead executive involved in legal and corporate affairs, according to an archived version on a website used to scan for malicious web addresses. Ohad Zaidenberg, lead intelligence researcher at Israeli cybersecurity firm ClearSky, who closely tracks Iranian hacking activity and has investigated the attacks, said the attempt was part of an effort by an Iranian group to compromise email accounts of staff at the company using messages that impersonated journalists.

Uncooked pet food could be source of pathogens dangerous to humans, research suggests

Michelle Chen

The post Will the Pandemic Lead to Better Treatment for Drug Users? appeared first on The Nation.

Remdesivir is currently the world’s best hope for treating COVID-19. But it’s not a silver bullet.

Thousands of drug convictions have been thrown out

Davidson is currently quarantining in his mother's basement

A quarter of all UK pharmacies have joined Hestia's 'UK SAYS NO MORE' campaign

Sharon Osbourne hoped seeing their father's battle with addiction would put her children off, but she was wrong.

An alleged cocaine drug ring spanning two states is uncovered by New South Wales and South Australian police, leading to the arrests of five people.

A NSW police officer is accused of "sloppy work" in an inquiry after she mistakenly inflated the quantity of drugs found on a reveller at Splendour in the Grass last year by nearly eight times.

Of more than 5,000 strip searches conducted by NSW police in the past financial year, less than a third found any illicit drugs, new data shows.

Under the proposal, if a person is found with drugs they would be referred to a health service one of more than 100 recommendations to be delivered next month.

AN EXOTIC dancer claims she was abused and “drugged into near unconsciousness” for not going along with a club’s scheme. WARNING: Graphic.

A team of scientists studied more than 1,300 patients admitted to a hospital for COVID-19

The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm [1] in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27 March 2020) in a Milan hospital, published in The Lancet Rheumatology journal.

Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the potential of accelerated new drug development.

Given the rapid spread of COVID-19 and its relatively high mortality, filling the gap for coronavirus-specific drugs is urgent.

A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration of viral shedding than lopinavir-ritonavir alone in patients with mild to moderate illness, according to the first randomized trial of this triple combination therapy involving 127 adults (aged 18 and older) from six public hospitals in Hong Kong.

Researchers did not track side effects, but noted a hint that hydroxychloroquine might have damaged other organs, too.

A Danish study of more than 200,000 patients has concluded that individuals with affective disorders who use benzodiazepines and other anxiolytics are not at increased risk of developing dementia.
Medscape Medical News

US President Donald Trump seemingly increases his estimate of possible deaths from coronavirus to 100,000, up from 70,000 earlier in the week, as South Africa, Spain and some American states loosen their restrictions. These are the key coronavirus developments from today.